Literature DB >> 17945472

Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors.

Kimberly L Douglas1, Ciriaco A Piccirillo, Maryam Tabrizian.   

Abstract

It has been suggested that cell physiology may affect the internalization pathways of non-viral vectors, leading to cell line-dependent transfection efficiency. To verify this hypothesis, fluorescently labeled alginate-chitosan nanoparticle complexes were used as non-viral vectors to transfect 293T, COS7, and CHO cells and to observe the cellular interactions and internalization mechanisms of the complexes in each cell line. 293T cells, which demonstrate the highest transfection efficiency, internalize complexes primarily through clathrin-mediated processes. COS7 cells also demonstrate some internalization of complexes through the clathrin-dependent pathway, explaining the moderate transfection exhibited. In contrast, CHO cells internalize complexes predominantly through caveolin-mediated pathways and are not transfected. Results suggest that following clathrin-mediated endocytosis, complexes are trafficked to the endo-lysosomal pathway, where the proton-sponge effect leads to their release into the cytosol. Contrarily, the absence of trafficking to this pathway following caveolin-mediated endocytosis results in vesicle-entrapped complexes that become transfection-incompetent. These results demonstrate that cell physiology is a critical factor in efficient transfection, and that trafficking to the endo-lysosomal pathway through specific internalization mechanisms is essential for transfection with alginate-chitosan nanoparticle complexes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17945472     DOI: 10.1016/j.ejpb.2007.09.002

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  58 in total

1.  Differential uptake of DNA-poly(ethylenimine) polyplexes in cells cultured on collagen and fibronectin surfaces.

Authors:  Anandika Dhaliwal; Maricela Maldonado; Zenas Han; Tatiana Segura
Journal:  Acta Biomater       Date:  2010-04-03       Impact factor: 8.947

2.  Chitosan nanoparticles are efficient carriers for delivering biodegradable drugs to neuronal cells.

Authors:  M Malatesta; V Galimberti; B Cisterna; M Costanzo; M Biggiogera; C Zancanaro
Journal:  Histochem Cell Biol       Date:  2013-12-20       Impact factor: 4.304

3.  pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.

Authors:  Tao Zhang; Timothy F Sturgis; Bi-Botti C Youan
Journal:  Eur J Pharm Biopharm       Date:  2011-06-26       Impact factor: 5.571

4.  Overexpression of caveolin-1 in inflammatory breast cancer cells enables IBC-specific gene delivery and prodrug conversion using histone-targeted polyplexes.

Authors:  Nikki L Ross; Millicent O Sullivan
Journal:  Biotechnol Bioeng       Date:  2016-06-09       Impact factor: 4.530

5.  Effectiveness of Small Interfering RNA Delivery via Arginine-Rich Polyethylenimine-Based Polyplex in Metastatic and Doxorubicin-Resistant Breast Cancer Cells.

Authors:  Shan Lu; Viola B Morris; Vinod Labhasetwar
Journal:  J Pharmacol Exp Ther       Date:  2019-04-02       Impact factor: 4.030

6.  Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention.

Authors:  Jianing Meng; Tao Zhang; Vivek Agrahari; Miezan J Ezoulin; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2014-01-10       Impact factor: 5.307

7.  Tumor-targeted RNA-interference: functional non-viral nanovectors.

Authors:  Xinghua Pan; Rachel Thompson; Xiaojie Meng; Daocheng Wu; Liang Xu
Journal:  Am J Cancer Res       Date:  2011-09-01       Impact factor: 6.166

8.  Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.

Authors:  Zhengxiong Li; Linlin Zhang; Cui Tang; Chunhua Yin
Journal:  Pharm Res       Date:  2017-09-25       Impact factor: 4.200

9.  Micelle Delivery of Parthenolide to Acute Myeloid Leukemia Cells.

Authors:  Michael P Baranello; Louisa Bauer; Craig T Jordan; Danielle S W Benoit
Journal:  Cell Mol Bioeng       Date:  2015-04-25       Impact factor: 2.321

10.  The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls.

Authors:  Dries Vercauteren; Roosmarijn E Vandenbroucke; Arwyn T Jones; Joanna Rejman; Joseph Demeester; Stefaan C De Smedt; Niek N Sanders; Kevin Braeckmans
Journal:  Mol Ther       Date:  2009-12-15       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.